https://www.healthlawasia.com/news/measures-for-public-security-organs-supervision-and-inspection-of-cyberspace-security/ 2026-09-17T15:51:37+00:00 https://www.healthlawasia.com/news/guidelines-for-data-property-rights-registration-trial/ 2026-09-17T15:45:31+00:00 https://www.healthlawasia.com/news/medical-security-law-of-the-peoples-republic-of-china/ 2026-09-17T15:37:09+00:00 https://www.healthlawasia.com/news/strategic-cooperation-agreement-between-centro-einaudi-and-health-law-asia/ 2026-09-17T15:27:10+00:00 https://www.healthlawasia.com/news/action-plan-for-promoting-rational-medication-use-among-older-adults-2026-2030/ 2026-07-28T05:38:07+00:00 https://www.healthlawasia.com/news/notice-of-the-state-council-on-issuing-the-national-health-plan-for-the-15th-five-year-plan-period/ 2026-07-28T05:33:42+00:00 https://www.healthlawasia.com/news/procedures-for-the-review-and-approval-of-applications-for-conditional-marketing-authorization-of-pharmaceutical-products/ 2026-07-28T05:30:07+00:00 https://www.healthlawasia.com/news/announcement-on-matters-concerning-the-application-of-the-priority-review-and-approval-procedures-for-drug-marketing-authorization-of-chemical-active-pharmaceutical-ingredients/ 2026-07-28T05:26:56+00:00 https://www.healthlawasia.com/news/interpretation-of-announcement-on-2026-medical-insurance-drug-catalog-preliminary-review-results/ 2026-07-15T05:06:29+00:00 https://www.healthlawasia.com/news/notice-on-ensuring-the-proper-implementation-of-work-related-to-the-segmented-manufacturing-of-biological-products/ 2026-07-15T04:33:10+00:00 https://www.healthlawasia.com/news/announcement-of-the-12th-national-centralized-volume-based-procurement-of-pharmaceuticals/ 2026-07-15T04:27:25+00:00 https://www.healthlawasia.com/news/guiding-principles-for-the-development-of-appropriate-pharmaceutical-packaging-specifications/ 2026-07-01T04:54:15+00:00 https://www.healthlawasia.com/news/guiding-opinions-on-the-standardized-development-of-modern-pharmaceutical-logistics-2/ 2026-07-01T04:44:52+00:00 https://www.healthlawasia.com/news/measures-for-the-administration-of-medical-representatives/ 2026-07-01T04:40:47+00:00 https://www.healthlawasia.com/news/model-anti-monopoly-case-ruled-by-the-supreme-peoples-court-huang-ltd-et-al/ 2026-07-01T04:37:00+00:00 https://www.healthlawasia.com/news/notice-on-issuing-the-compliance-guidelines-for-the-online-retail-sale-of-prescription-drugs/ 2026-06-16T01:06:54+00:00 https://www.healthlawasia.com/news/good-clinical-practice-for-drug-trials/ 2026-06-16T01:02:42+00:00 https://www.healthlawasia.com/news/announcement-on-strengthening-the-supervision-and-administration-of-entrusted-drug-manufacturing/ 2026-06-16T00:57:12+00:00 https://www.healthlawasia.com/news/administrative-public-interest-litigation-case-regarding-the-rectification-of-disguised-sales-of-prohibited-online-medicines-in-the-form-of-false-online-consultations/ 2026-06-16T00:48:59+00:00 https://www.healthlawasia.com/news/regulations-on-inspection-of-exported-drugs-and-management-of-export-certificates-for-pharmaceutical-manufacturers/ 2026-06-03T01:57:17+00:00 https://www.healthlawasia.com/news/regulations-on-the-administration-of-clinical-research-and-clinical-translational-application-of-new-biomedical-technologies/ 2026-06-03T01:44:32+00:00 https://www.healthlawasia.com/news/implementation-measures-for-drug-trial-data-protection/ 2026-06-03T01:05:57+00:00 https://www.healthlawasia.com/news/implementation-opinions-on-promoting-the-integration-of-artificial-intelligence-into-drug-regulation/ 2026-06-03T00:31:56+00:00 https://www.healthlawasia.com/news/singapore-and-japan-strenghten-regulatory-cooperation-in-health-products/ 2026-06-01T01:02:08+00:00 https://www.healthlawasia.com/news/bristol-myers-squibb-hengrui-global-collaboration-agreement/ 2026-05-22T03:03:47+00:00 https://www.healthlawasia.com/news/further-optimizing-the-review-and-approval-of-clinically-urgently-needed-overseas-marketed-drugs/ 2026-05-18T07:26:39+00:00 https://www.healthlawasia.com/news/opinions-on-improving-the-drug-price-formation-mechanism/ 2026-05-18T07:21:34+00:00 https://www.healthlawasia.com/news/guiding-opinions-on-the-standardized-development-of-modern-pharmaceutical-logistics/ 2026-05-18T07:11:59+00:00 https://www.healthlawasia.com/news/singapores-hsa-starts-accepting-ectd-packages-for-regulatory-dossier-applications/ 2026-04-20T04:36:12+00:00 https://www.healthlawasia.com/news/cmef-2026-in-shanghai-a-global-hub-for-medical-innovation-and-ai-driven-healthcare/ 2026-04-13T03:09:00+00:00 https://www.healthlawasia.com/news/astrazeneca-establishes-end-to-end-cell-therapy-capabilities-in-shanghai/ 2026-04-02T02:06:12+00:00 https://www.healthlawasia.com/news/china-15th-five-year-plan-and-its-implications-for-the-healthcare-industry/ 2026-03-26T06:19:48+00:00 https://www.healthlawasia.com/news/chinese-commerce-minister-meets-pharma-executives-to-promote-foreign-investment/ 2026-03-23T07:32:38+00:00 https://www.healthlawasia.com/news/several-measures-to-support-the-high-quality-development-of-innovative-drugs/ 2025-10-22T00:12:59+00:00 https://www.healthlawasia.com/news/rewards-for-internal-informants-reporting-issues-concerning-the-quality-and-safety-of-medicinal-products-and-medical-devices/ 2025-10-22T00:09:43+00:00 https://www.healthlawasia.com/news/further-enhancing-matters-related-to-the-issuance-of-the-drug-manufacturing-license/ 2025-10-22T00:05:49+00:00 https://www.healthlawasia.com/news/import-of-commercial-scale-batches-of-drugs-already-marketed-abroad-and-produced-prior-to-approval-in-china/ 2025-10-22T00:03:30+00:00 https://www.healthlawasia.com/news/antimonopoly-guidelines-for-the-pharmaceutical-sector/ 2025-10-21T23:59:22+00:00 https://www.healthlawasia.com/news/guidelines-for-pharmaceutical-companies-to-prevent-commercial-bribery-risks/ 2025-10-21T08:08:04+00:00